You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
回盛生物(300871.SZ):全資子公司米氮平軟膏獲得膏新獸藥註冊證書
格隆匯 01-06 20:09

格隆匯1月6日丨回盛生物(300871.SZ)公佈,根據《獸藥管理條例》和《獸藥註冊辦法》規定,經中華人民共和國農業農村部審查,批准武漢回盛生物科技股份有限公司全資子公司湖北迴盛生物科技有限公司與其他單位聯合申報的“米氮平軟膏”為新獸藥,農業農村部於2025年1月3日核發了《新獸藥註冊證書》(農業農村部公吿第871號)。

由於寵物貓生理特點和行為習慣的特殊性,寵物貓的健康問題也日益受到重視。寵物食慾下降、體重減輕是引發貓健康問題的一個重要臨牀體徵,若不干預會進一步對貓健康造成嚴重的危害。公司充分考慮寵物臨牀用藥需求,經過系統科學地研究,成功研發出新獸藥米氮平軟膏。該新獸藥產品具有安全有效、質量可控、使用便捷的特點。

截至目前,公司通過公開渠道未能獲得市場其他公司同類產品具體銷售數據。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account